{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:26:47Z","timestamp":1762212407157,"version":"build-2065373602"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,3]]},"DOI":"10.7759\/cureus.96026","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:22:58Z","timestamp":1762212178000},"source":"Crossref","is-referenced-by-count":0,"title":["Cerebral Small Vessel Disease: Bystander or Culprit?"],"prefix":"10.7759","author":[{"given":"Emma L","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hla Hla","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eluzai","family":"Abe Hakim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni L","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010, 9:689-701. 10.1016\/S1474-4422(10)70104-6","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000179092.59909.42","article-title":"Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study","volume":"36","author":"van der Flier WM","year":"2005","unstructured":"van der Flier WM, van Straaten EC, Barkhof F, et al.. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke. 2005, 36:2116-20. 10.1161\/01.STR.0000179092.59909.42","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.124651","article-title":"White matter hyperintensities in late life depression: a systematic review","volume":"79","author":"Herrmann LL","year":"2008","unstructured":"Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry. 2008, 79:619-24. 10.1136\/jnnp.2007.124651","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq343","article-title":"Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease","volume":"134","author":"de Laat KF","year":"2011","unstructured":"de Laat KF, Tuladhar AM, van Norden AG, Norris DG, Zwiers MP, de Leeuw FE. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain. 2011, 134:73-83. 10.1093\/brain\/awq343","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Gorelick PB","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, et al.. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011, 42:2672-713. 10.1161\/STR.0b013e3182299496","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/17474930221144911","article-title":"Cerebral small vessel disease: recent advances and future directions","volume":"18","author":"Markus HS","year":"2023","unstructured":"Markus HS, de Leeuw FE. Cerebral small vessel disease: recent advances and future directions. Int J Stroke. 2023, 18:4-14. 10.1177\/17474930221144911","journal-title":"Int J Stroke"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.031609","article-title":"Top-NOTCH3 variants in the population at large","volume":"51","author":"Kalaria RN","year":"2020","unstructured":"Kalaria RN, Kittner SJ. Top-NOTCH3 variants in the population at large. Stroke. 2020, 51:3482-4. 10.1161\/STROKEAHA.120.031609","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.344","article-title":"Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL","volume":"3","author":"Rutten JW","year":"2016","unstructured":"Rutten JW, Dauwerse HG, Gravesteijn G, et al.. Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL. Ann Clin Transl Neurol. 2016, 3:844-53. 10.1002\/acn3.344","journal-title":"Ann Clin Transl Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030343","article-title":"Cysteine-altering NOTCH3 variants are a risk factor for stroke in the elderly population","volume":"51","author":"Hack RJ","year":"2020","unstructured":"Hack RJ, Rutten JW, Person TN, et al.. Cysteine-altering NOTCH3 variants are a risk factor for stroke in the elderly population. Stroke. 2020, 51:3562-9. 10.1161\/STROKEAHA.120.030343","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.024151","article-title":"Genetics of cerebral small vessel disease","volume":"51","author":"Marini S","year":"2020","unstructured":"Marini S, Anderson CD, Rosand J. Genetics of cerebral small vessel disease. Stroke. 2020, 51:12-20. 10.1161\/STROKEAHA.119.024151","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging","volume":"12","author":"Wardlaw JM","year":"2013","unstructured":"Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013, 12:483-97. 10.1016\/S1474-4422(13)70060-7","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0778-8","article-title":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects","volume":"15","author":"Di Donato I","year":"2017","unstructured":"Di Donato I, Bianchi S, De Stefano N, et al.. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med. 2017, 15:41. 10.1186\/s12916-017-0778-8","journal-title":"BMC Med"},{"key":"ref13","article-title":"CADASIL","author":"Hack RJ","year":"2000","unstructured":"Hack RJ, Rutten J, Lesnik Oberstein SA. CADASIL. Adam MP, Feldman J, Mirzaa GM, et al. (ed): GeneReviews\u00ae, Seattle (WA); 2000."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/429005-cerebral-small-vessel-disease-bystander-or-culprit","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:23:04Z","timestamp":1762212184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/429005-cerebral-small-vessel-disease-bystander-or-culprit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.96026","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}